|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Immunome (NASDAQ: IMNM) through any online brokerage.
There are no as such competitors for Immunome.
The latest price target for Immunome (NASDAQ: IMNM) was reported by Cantor Fitzgerald on October 29, 2021. The analyst firm set a price target for 35.00 expecting IMNM to rise to within 12 months (a possible 125.23% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Immunome (NASDAQ: IMNM) is $15.54 last updated Today at 3:18:49 PM.
There are no upcoming dividends for Immunome.
Immunome’s $Q3 earnings are confirmed for after-market on November 15, 2021.
There is no upcoming split for Immunome.
Immunome is in the sector and industry. They are listed on the NASDAQ.